From: Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma
Parameters | Cases | HSPA2 expression (n) | χ2 | P value | |
---|---|---|---|---|---|
Positive | Negative | ||||
Tissues | |||||
Cancer | 120 | 90 | 30 | 21.343 | 0.000 |
Adjacent | 120 | 55 | 65 | ||
Age (years) | |||||
≤60 | 81 | 64 | 17 | 2.140 | 0.144 |
>60 | 39 | 26 | 13 | ||
Gender | |||||
Male | 90 | 69 | 21 | 0.533 | 0.465 |
Female | 30 | 21 | 9 | ||
Drinking | |||||
Yes | 75 | 59 | 16 | 1.434 | 0.231 |
No | 45 | 31 | 14 | ||
Tumor site | |||||
Upper | 35 | 26 | 9 | 0.017 | 0.992 |
Middle | 40 | 30 | 10 | ||
Lower | 45 | 34 | 11 | ||
Grade | |||||
G1 | 63 | 49 | 14 | 0.672 | 0.715 |
G2 | 30 | 21 | 9 | ||
G3 + G4 | 27 | 20 | 7 | ||
Primary tumor | |||||
T1 | 30 | 18 | 12 | 9.340 | 0.025a |
T2 | 31 | 21 | 10 | ||
T3 | 42 | 35 | 7 | ||
T4 | 17 | 16 | 1 | ||
TNM stage | |||||
I | 28 | 14 | 14 | 14.991 | 0.001a |
II | 49 | 37 | 12 | ||
III | 43 | 39 | 4 | ||
Lymph node metastases | |||||
N0 | 76 | 51 | 25 | 6.890 | 0.009a |
N+ | 44 | 39 | 5 | ||
Recurrenceb | |||||
Yes | 85 | 70 | 15 | 8.497 | 0.004a |
No | 32 | 18 | 14 |